HLA-B and COVID-19: This list included the HLA-B*40:01-restricted SARS-CoV-2-derived peptides GEAANFCAL, GEVITFDNL, and FIAGLIAIV which have been independently shown to induce T cell response, INF-γ production, and proliferation in COVID-19 patients (66, 70).